BRNS - CIK 0001828185
Barinthus Biotherapeutics plc. has filed 247 documents with the SEC between 2020 and 2026. The most frequent type is insider trade (79 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Quarterly report | 10-Q | 2023-05-12 | 2023-03-31 |
| Major company event | 8-K | 2023-05-12 | 2023-05-12 |
| Major company event | 8-K | 2023-05-11 | 2023-05-11 |
| Major company event | 8-K | 2023-04-28 | 2023-03-24 |
| Annual report to shareholders | ARS | 2023-04-19 | 2022-12-31 |
| Insider trade | 4 | 2023-03-29 | 2023-01-03 |
| Insider trade | 4 | 2023-03-29 | 2023-01-03 |
| Insider trade | 4 | 2023-03-29 | 2023-03-27 |
| Proxy statement | DEF 14A | 2023-03-29 | 2023-05-11 |
| Employee stock plan | S-8 | 2023-03-24 | - |
| Annual report | 10-K | 2023-03-24 | 2022-12-31 |
| Major company event | 8-K | 2023-03-24 | 2023-03-24 |
| Insider trade | 4 | 2023-02-24 | 2023-02-01 |
| New insider ownership | 3 | 2023-02-24 | 2023-01-30 |
| Insider trade | 4 | 2023-02-23 | 2023-01-03 |
| Insider trade | 4 | 2023-02-23 | 2023-01-03 |
| Insider trade | 4 | 2023-02-23 | 2023-01-03 |
| Insider trade | 4 | 2023-02-23 | 2023-01-03 |
| Annual insider summary | 5 | 2023-02-10 | 2022-12-31 |
| Annual insider summary | 5 | 2023-02-10 | 2022-12-31 |
| Annual insider summary | 5 | 2023-02-10 | 2022-12-31 |
| Annual insider summary | 5 | 2023-02-10 | 2022-12-31 |
| Annual insider summary | 5 | 2023-02-10 | 2022-12-31 |
| Annual insider summary | 5 | 2023-02-10 | 2022-12-31 |
| Passive ownership stake (update) | SC 13G/A | 2023-01-20 | - |
| Quarterly report | 10-Q | 2022-11-10 | 2022-09-30 |
| Major company event | 8-K | 2022-11-10 | 2022-11-10 |
| Passive ownership stake | SC 13G | 2022-10-07 | - |
| Insider trade | 4 | 2022-10-04 | 2022-09-30 |
| Insider trade | 4 | 2022-10-04 | 2022-09-30 |
| Major company event (amended) | 8-K/A | 2022-09-30 | 2022-09-15 |
| Insider trade | 4 | 2022-09-28 | 2022-09-26 |
| New insider ownership | 3 | 2022-09-23 | 2022-09-15 |
| Major company event | 8-K | 2022-09-20 | 2022-09-14 |
| Insider trade | 4 | 2022-08-26 | 2022-08-25 |
| Insider trade | 4 | 2022-08-26 | 2022-08-24 |
| Insider trade | 4 | 2022-08-19 | 2022-08-17 |
| Insider trade | 4 | 2022-08-19 | 2022-08-17 |
| EFFECT | - | 2022-08-17 | - |
| Insider trade | 4 | 2022-08-17 | 2022-08-15 |
| Insider trade | 4 | 2022-08-17 | 2022-08-15 |
| Insider trade | 4 | 2022-08-15 | 2022-08-12 |
| Company correspondence | CORRESP | 2022-08-15 | - |
| SEC correspondence | UPLOAD | 2022-08-12 | - |
| S-3/A | - | 2022-08-10 | - |
| Securities registration | S-3 | 2022-08-09 | - |
| Quarterly report | 10-Q | 2022-08-09 | 2022-06-30 |
| Major company event | 8-K | 2022-08-09 | 2022-08-09 |
| Insider trade | 4 | 2022-07-15 | 2022-06-28 |
| Insider trade | 4 | 2022-07-15 | 2022-06-23 |